Terumasa Ikeda

8.2k total citations
43 papers, 809 citations indexed

About

Terumasa Ikeda is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Terumasa Ikeda has authored 43 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 20 papers in Virology and 14 papers in Molecular Biology. Recurrent topics in Terumasa Ikeda's work include HIV Research and Treatment (20 papers), Cytomegalovirus and herpesvirus research (11 papers) and HIV/AIDS drug development and treatment (11 papers). Terumasa Ikeda is often cited by papers focused on HIV Research and Treatment (20 papers), Cytomegalovirus and herpesvirus research (11 papers) and HIV/AIDS drug development and treatment (11 papers). Terumasa Ikeda collaborates with scholars based in Japan, United States and Egypt. Terumasa Ikeda's co-authors include Atsushi Koito, Reuben S. Harris, William L. Brown, Shuzo Matsushita, Kazuhisa Yoshimura, Junji Shibata, Nadine M. Shaban, Emily K. Law, Michael A. Carpenter and Ming Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Terumasa Ikeda

42 papers receiving 800 citations

Peers

Countries citing papers authored by Terumasa Ikeda

Since Specialization

Citations

This map shows the geographic impact of Terumasa Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terumasa Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terumasa Ikeda more than expected).

Fields of papers citing papers by Terumasa Ikeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terumasa Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terumasa Ikeda. The network helps show where Terumasa Ikeda may publish in the future.

Co-authorship network of co-authors of Terumasa Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Terumasa Ikeda. A scholar is included among the top collaborators of Terumasa Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terumasa Ikeda. Terumasa Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Possible Crosstalk and Alterations in Gut Bacteriome and Virome in HIV-1 Infection and the Associated Comorbidities Related to Metabolic Disorder 2025 ·Viruses ·(unknown), Hesham Nasser, Terumasa Ikeda, Vijay Nema	2
2	SARS-CoV-2 inactivation: assessing the efficacy of GO-anchored filters versus various commercial masks 2024 ·RSC Applied Interfaces ·Md. Saidul Islam, (unknown), MST Monira Begum, (unknown), (unknown), (unknown), Kenji Sadamasu, Kazuhisa Yoshimura, Junko Matsuda, Yoshihiro Sekine, Terumasa Ikeda, Shinya Hayami	1
3	Virological characteristics correlating with SARS-CoV-2 spike protein fusogenicity 2024 ·SHILAP Revista de lepidopterología ·MST Monira Begum, Kimiko Ichihara, Otowa Takahashi, Hesham Nasser, Michael Jonathan, Kenzo Tokunaga, Isao Yoshida, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, Kei Sato, Terumasa Ikeda	5
4	Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses 2024 ·Proceedings of the National Academy of Sciences ·(unknown), Jun‐ichirou Yasunaga, Kei Sato, Kisato Nosaka, (unknown), Miho Watanabe, (unknown), Yoshio Koyanagi, Edward L. Murphy, Roberta Bruhn, Ki‐Ryang Koh, Hirofumi Akari, Terumasa Ikeda, Reuben S. Harris, Patrick L. Green, Masao Matsuoka	13
5	Potential Role of APOBEC3 Family Proteins in SARS-CoV-2 Replication 2024 ·Viruses ·MST Monira Begum, (unknown), (unknown), (unknown), (unknown), Kazuhisa Yoshimura, Yorifumi Satou, Diako Ebrahimi, Terumasa Ikeda	1
6	SARS-CoV-2 suppression depending on the pH of graphene oxide nanosheets 2023 ·Nanoscale Advances ·Md. Saidul Islam, Masahiro Fukuda, Md Jakir Hossain, (unknown), (unknown), Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, Yoshihiro Sekine, Terumasa Ikeda, Shinya Hayami	5
7	Characterization of the evolutionary and virological aspects of mutations in the receptor binding motif of the SARS-CoV-2 spike protein 2023 ·SHILAP Revista de lepidopterología ·(unknown), Hesham Nasser, Jiří Zahradník, Shuya Mitoma, Ryo Shimizu, Kayoko Nagata, Akifumi Takaori‐Kondo, Gideon Schreiber, Kotaro Shirakawa, Akatsuki Saito, Terumasa Ikeda, Jumpei Ito, Kei Sato	3
8	APOBEC3 family proteins as drivers of virus evolution 2023 ·SHILAP Revista de lepidopterología ·Michael Jonathan, Terumasa Ikeda	6
9	A SARS-CoV-2 Delta variant containing mutation in the probe binding region used for RT-qPCR test in Japan exhibited atypical PCR amplification and might induce false negative result 2022 ·Journal of Infection and Chemotherapy ·(unknown), (unknown), (unknown), Terumasa Ikeda, (unknown), Tatsuya Kawaguchi, Yorifumi Satou	5
10	Lethal Interactions of SARS-CoV-2 with Graphene Oxide: Implications for COVID-19 Treatment 2021 ·ACS Applied Nano Materials ·Masahiro Fukuda, Md. Saidul Islam, Ryo Shimizu, Hesham Nasser, (unknown), Yukie Takahashi, Yoshihiro Sekine, Leonard F. Lindoy, (unknown), Terumasa Ikeda, Shinya Hayami	44
11	Genetic and mechanistic basis for APOBEC3H alternative splicing, retrovirus restriction, and counteraction by HIV-1 protease 2018 ·Nature Communications ·Diako Ebrahimi, Christopher M. Richards, Michael A. Carpenter, (unknown), Terumasa Ikeda, Jordan T. Becker, Adam Z. Cheng, Jennifer L. McCann, Nadine M. Shaban, Daniel J. Salamango, Gabriel J. Starrett, Jairam R. Lingappa, Jeongsik Yong, William L. Brown, Reuben S. Harris	26
12	HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G 2018 ·PLoS Pathogens ·Terumasa Ikeda, (unknown), John S. Albin, Ming Li, Markus Thali, Reuben S. Harris	31
13	Opossum APOBEC1 is a DNA mutator with retrovirus and retroelement restriction activity 2017 ·Scientific Reports ·Terumasa Ikeda, (unknown), Diako Ebrahimi, John L. VandeBerg, Reuben S. Harris, Atsushi Koito, Kazuhiko Maeda	12
14	Evaluation of sequence variability in HIV-1 gp41 C-peptide helix-grafted proteins 2017 ·Bioorganic & Medicinal Chemistry ·(unknown), Susanne N. Walker, Terumasa Ikeda, Reuben S. Harris, (unknown)	3
15	Creation of chimeric human/rabbit APOBEC1 with HIV-1 restriction and DNA mutation activities 2016 ·Scientific Reports ·Terumasa Ikeda, (unknown), Nobumoto Watanabe, Nobuo Sakaguchi, Kazuhiko Maeda, Atsushi Koito	9
16	Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases 2013 ·Frontiers in Microbiology ·Atsushi Koito, Terumasa Ikeda	76
17	The Local Dinucleotide Preference of APOBEC3G Can Be Altered from 5′-CC to 5′-TC by a Single Amino Acid Substitution 2013 ·Journal of Molecular Biology ·Anurag S. Rathore, Michael A. Carpenter, Özlem Demir, Terumasa Ikeda, Ming Li, Nadine M. Shaban, Emily K. Law, (unknown), William L. Brown, Rommie E. Amaro, Reuben S. Harris	77
18	Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons 2011 ·Nucleic Acids Research ·Terumasa Ikeda, Khaled H. Abd El Galil, Kenzo Tokunaga, Kazuhiko Maeda, Tetsutaro Sata, Nobuo Sakaguchi, Thiérry Heidmann, Atsushi Koito	54
19	The antiretroviral potency of APOBEC1 deaminase from small animal species 2008 ·Nucleic Acids Research ·Terumasa Ikeda, Takeo Ohsugi, Tetsuya Kimura, Shuzo Matsushita, Yosuke Maeda, Shinji Harada, Atsushi Koito	37
20	Recurrent HIV‐1 Integration at theBACH2Locus in Resting CD4⁺T Cell Populations during Effective Highly Active Antiretroviral Therapy 2007 ·The Journal of Infectious Diseases ·Terumasa Ikeda, Junji Shibata, Kazuhisa Yoshimura, Atsushi Koito, Shuzo Matsushita	94

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact